Global Protein Market Analysis 2017-2018 & Forecast to 2023 with Subfocus on Oncoproteomics

News provided by

Sep 27, 2018, 10:15 ET

DUBLIN, Sept. 27, 2018 /PRNewswire/ --

The "Protein Analysis: Subfocus on Oncoproteomics" report has been added to ResearchAndMarkets.com's offering.

Rising demand and U.S. Food and Drug Administration (FDA) approvals of personalized medicines due to their numerous benefits have been two of the major factors driving the market growth. As protein analysis is widely used for personalized medicines, it enables the market to grow significantly. Additionally, a rising aging population and an increase in lifestyle diseases have been motivating the market. According to theWorld Health Organization, cardiovascular diseases (CVDs) have been estimated as one of the major causes of mortality, and they account for more than 17.3 million deaths per year. It is further estimated that the fatalities due to CVDs are expected to reach 23.6 million by 2030.

These lifestyle diseases are growing at a significant rate, and protein analysis can be act as a bridge for drug discovery, customized medicines, biomarkers and research programs. Further, the diabetic population was recorded as 415 million in 2015, and it is projected that this will reach 642 million by 2040. This prevalence of lifestyle-related disorders reflects the need for protein analysis as a bridge for the drug discovery, customized medicines, and biomarkers, thus promoting the market. Healthcare research and development (R&D) spending plays a significant role in the growth of the protein analysis market. As transformative research is responsible for the development of new biomarkers and next-generation diagnostics and therapeutics, healthcare expenditure is a crucial element for the market.

Globally, national governments have been revising their healthcare expenditure taking into account increasing R&D. As a result, the overall increase in the healthcare expenditure globally would drive the market, as research institutes will be able to obtain increased funding by governments for drug discovery. Strict regulatory approvals of protein analysis instruments have been one of the major restraints of the protein analysis market. These products require regulatory approval by the FDA and other regulatory bodies as they govern a broad range of activities such as quality management, design and development, labeling, manufacturing and so forth. Additionally, there are various regulations for manufacturers and their customers, along with regulations in the areas of health and safety, packaging, product content and trade restrictions.

Manufacturers are required to follow complex foreign and U.S. laws and regulations, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other local laws, violations of which can result in penalties and restrictions on the conduct of business. Additionally, the high costs of these instruments affect their adoption in the industry. Both of these factors have a negative effect on the growth of protein analysis market. However, technological advancements in mass spectrometry/liquid chromatography (MS/LC) instrumentation, protein separation and emerging markets in developing economies such as China, Japan, and South Korea are expected to drive the market growth in the upcoming years.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Driving Forces
Ongoing Research in Personalized Medicine
Aging Population and Increase in Lifestyle-Related Diseases
Rising Healthcare and R&D Expenditures
Restraints
Tough Regulatory Approvals
High Cost of Protein Analysis Instruments and Equipment
Opportunities
Technological Advancements
Emerging Markets
Protein Analysis
Technology Platforms
Biochip-based Protein Analysis Technologies
Onco-Protein Analysis

Chapter 4 Market Breakdown by End Use

Drug Discovery and R&D
Clinical Diagnosis
Others

Chapter 5 Market Breakdown by Instrumentation/Reagent Technology

Mass Spectrometry
Mass Spectrometry Imaging
Biochips
Protein Microarrays
Chromatography
Microscale Thermophoresis
NMR Spectroscopy
Electrophoresis
Capillary Electrophoresis
Others
X-Ray Crystallography Instrumentation
Protein Fractionation

Chapter 6 Market Breakdown by Type of Disease/Diagnostic

Cancer
Bladder Cancer
Breast Cancer
Colorectal Cancer
Gastric Cancer
Kidney Cancer
Lung Cancer
Lymphoma Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Thyroid Cancer
Infectious Diseases
Diabetes
Neurological Disorders
Alzheimer's Disease
Schizophrenia
Cardiovascular Diseases
Autoimmune Diseases
HLA Typing
Prenatal Testing

Chapter 7 Market Breakdown by Type of Service and Industry Application

Quantitative Services
Laboratory Services
Simple Protein Identification
Multidimensional LC-MS
Protein Mass Spectrometry
2D Difference Gel Electrophoresis
Protein Profiling
Protein-Identification and Separation Services
Protein Sequencing Services
Protein-Imaging Services
Breakdown by Application Industry
Biotechnology Industry
Pharmaceutical Industry
Other (Research Institutes and Academics)
Market Breakdown by Service
Market Breakdown by Industry
Biotechnology Industry Applications by Region
Pharmaceutical Industry Applications by Region
Other Industry Applications by Region

Chapter 8 Market Breakdown by Region

Chapter 9 Patent Review/New Developments

Competitive Landscape
Top Companies
Key Strategies

Chapter 10 Company Profiles

Abcodia
Advance Proteome Therapeutics Corp.
Agilent Technologies Inc.
Anatrace
Applied Microarrays Inc.
Arrayit Corp.
Astute Medical Inc.
Avacta
Ayoxxa Biosystems Gmbh
Biodesix Inc.
Biognosys Ag
Biomerieux
Bioproximity
Bio-Rad Laboratories Inc.
Bio-Techne Inc.
Brucker
Cambridge Protein Arrays Ltd.
Caprion Biosciences Inc.
Cdi Laboratories Inc.
Creative Proteomics Inc.
Crelux Gmbh
Crystalgenomics
Danaher Corp.
Epicypher
Evotec
Fluidigm
Ge Healthcare
Glaxosmithkline Plc
Gd Biosciences
Gl Sciences
Healthtell
Hybrigenics Sa
Immunovia
Imtakt Corp.
Integrated Diagnostics Inc.
Indi Molecular
Labcyte Inc.
Luminex Corp.
Merck Kgaa
Mosaiques Diagnostics And Therapeutics Ag
MRM Proteomics
MS Bioworks Llc
Mycartis
Myriad Genetics Inc.
Nantomics
Newomics
Nirmidas Biotech
Opko Health Inc.
Perkinelmer
Pfizer
Phylogica
Pressure Biosciences Inc.
Prometic Life Science Inc.
Protagen Ag
Protea Biosciences Inc.
Proteocyte Ai
Proteogenix
Proteome Sciences
Proteomics International
Proteovista
Qiagen Nv
Quansys Biosciences
Quanterix
Quest Diagnostics
Raybiotec
Repligen Corp.
Retrogenix
Samdi Tech Inc.
Sera Prognostics
Shimadzu Corp.
Showa Danko Kk
Sigma-Aldrich Corp.
Siscapa Assay Technologies
Somalogic Inc.
Sphere Fluidics
Spoton Clinical Diagnostics
SQI Diagnostics
Thermofisher Scientific Inc.
Thorne Diagnostics
Vermillion
Waters Corp.
Xencor

For more information about this report visit https://www.researchandmarkets.com/research/zs2ms7/global_protein?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets